Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial.

Margolin KA, Liu PY, Unger JM, Fletcher WS, Flaherty LE, Urba WJ, Hersh EM, Hutchins LE, Sosman JA, Smith JW, Weiss GR, Sondak VK
J Cancer Res Clin Oncol. 1999 125 (5): 292-6

PMID: 10359134 · DOI:10.1007/s004320050276

MeSH Terms (18)

Adolescent Adult Aged Antineoplastic Agents, Alkylating Antineoplastic Agents, Hormonal Antineoplastic Combined Chemotherapy Protocols Cisplatin Dacarbazine Drug Administration Schedule Female Humans Interferon-alpha Male Melanoma Middle Aged Southwestern United States Tamoxifen Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: